BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20124699)

  • 1. Structure of human desArg-C5a.
    Cook WJ; Galakatos N; Boyar WC; Walter RL; Ealick SE
    Acta Crystallogr D Biol Crystallogr; 2010 Feb; 66(Pt 2):190-7. PubMed ID: 20124699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
    Nikiforovich GV; Marshall GR; Baranski TJ
    Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dimerization domain of HNF-1alpha: structure and plasticity of an intertwined four-helix bundle with application to diabetes mellitus.
    Narayana N; Hua Q; Weiss MA
    J Mol Biol; 2001 Jul; 310(3):635-58. PubMed ID: 11439029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of model and nuclear magnetic resonance structures for the human inflammatory protein C5a.
    Zuiderweg ER; Henkin J; Mollison KW; Carter GW; Greer J
    Proteins; 1988; 3(3):139-45. PubMed ID: 3255102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
    J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding.
    Zhang X; Boyar W; Galakatos N; Gonnella NC
    Protein Sci; 1997 Jan; 6(1):65-72. PubMed ID: 9007977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
    Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
    J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8.
    Qian YQ; Johanson KO; McDevitt P
    J Mol Biol; 1999 Dec; 294(5):1065-72. PubMed ID: 10600366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of Delta 5-3-ketosteroid isomerase complexed with the steroid 19-nortestosterone hemisuccinate.
    Massiah MA; Abeygunawardana C; Gittis AG; Mildvan AS
    Biochemistry; 1998 Oct; 37(42):14701-12. PubMed ID: 9778345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer.
    Yatime L; Maasch C; Hoehlig K; Klussmann S; Andersen GR; Vater A
    Nat Commun; 2015 Apr; 6():6481. PubMed ID: 25901944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The putative DNA-binding protein Sto12a from the thermoacidophilic archaeon Sulfolobus tokodaii contains intrachain and interchain disulfide bonds.
    Shinkai A; Sekine S; Urushibata A; Terada T; Shirouzu M; Yokoyama S
    J Mol Biol; 2007 Oct; 372(5):1293-304. PubMed ID: 17720190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Base of molecular mimicry between human ribosomal protein S19 dimer and human C5a anaphylatoxin.
    Nishiura H; Chen J; Ota Y; Semba U; Higuchi H; Nakashima T; Yamamoto T
    Int Immunopharmacol; 2010 Dec; 10(12):1541-7. PubMed ID: 20869475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structures of the core light-harvesting alpha and beta polypeptides from Rhodospirillum rubrum: implications for the pigment-protein and protein-protein interactions.
    Wang ZY; Gokan K; Kobayashi M; Nozawa T
    J Mol Biol; 2005 Mar; 347(2):465-77. PubMed ID: 15740753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structure of murine macrophage inflammatory protein-2.
    Shao W; Jerva LF; West J; Lolis E; Schweitzer BI
    Biochemistry; 1998 Jun; 37(23):8303-13. PubMed ID: 9622482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural study of Ac-Phe-[Orn-Pro-dCha-Trp-Arg], a potent C5a receptor antagonist, by NMR.
    Zhang L; Mallik B; Morikis D
    Biopolymers; 2008; 90(6):803-15. PubMed ID: 18846566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased survival of human breast cancer cells expressing HER2/neu on in vitro incubation with an anti-HER2/neu antibody fused to C5a or C5a desArg.
    Fuenmayor J; Perez-Vazquez K; Perez-Witzke D; Penichet ML; Montano RF
    Mol Cancer Ther; 2010 Aug; 9(8):2175-85. PubMed ID: 20682652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of C5a/C5a(desArg) in bovine plasma, serum and milk.
    Rainard P; Sarradin P; Paape MJ; Poutrel B
    Vet Res; 1998; 29(1):73-88. PubMed ID: 9559522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex.
    Huang Y; Fedarovich A; Tomlinson S; Davies C
    Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):714-21. PubMed ID: 17505110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The solution structure of bovine ferricytochrome b5 determined using heteronuclear NMR methods.
    Muskett FW; Kelly GP; Whitford D
    J Mol Biol; 1996 Apr; 258(1):172-89. PubMed ID: 8613986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the functional fragment of auxilin required for catalytic uncoating of clathrin-coated vesicles.
    Gruschus JM; Han CJ; Greener T; Ferretti JA; Greene LE; Eisenberg E
    Biochemistry; 2004 Mar; 43(11):3111-9. PubMed ID: 15023062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.